Bloedingsrisico bij gebruik van fluoxetine (Prozac) of fluvoxamine (Fevarin)

J P Ottervanger; P M van den Bemt; G H de Koning; B H Stricker

Bloedingsrisico bij gebruik van fluoxetine (Prozac) of fluvoxamine (Fevarin)

Translated title of the contribution: Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin)

J P Ottervanger
, P M van den Bemt
, G H de Koning
, B H Stricker

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Fluoxetine (Prozac) and fluvoxamine (Fevarin) are nontricyclic serotonin (5-hydroxytryptamine) reuptake inhibitors prescribed for the treatment of depression. Since these drugs block serotonin reuptake in platelets also, they might under certain conditions lead to clinically significant platelet dysfunction. Four patients are described who developed bleeding during treatment with either fluoxetine or fluvoxamine.

Translated title of the contribution	Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin)
Original language	Dutch
Pages (from-to)	259-61
Number of pages	3
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	137
Issue number	5
Publication status	Published - 30 Jan 1993
Externally published	Yes

Keywords

Adult
Female
Fluoxetine/adverse effects
Fluvoxamine/adverse effects
Hematoma/chemically induced
Hemorrhage/chemically induced
Humans

Cite this

@article{b3312004ece846d1ac3d3ba7ebb52b91,

title = "Bloedingsrisico bij gebruik van fluoxetine (Prozac) of fluvoxamine (Fevarin)",

abstract = "Fluoxetine (Prozac) and fluvoxamine (Fevarin) are nontricyclic serotonin (5-hydroxytryptamine) reuptake inhibitors prescribed for the treatment of depression. Since these drugs block serotonin reuptake in platelets also, they might under certain conditions lead to clinically significant platelet dysfunction. Four patients are described who developed bleeding during treatment with either fluoxetine or fluvoxamine.",

keywords = "Adult, Female, Fluoxetine/adverse effects, Fluvoxamine/adverse effects, Hematoma/chemically induced, Hemorrhage/chemically induced, Humans",

author = "Ottervanger, \{J P\} and \{van den Bemt\}, \{P M\} and \{de Koning\}, \{G H\} and Stricker, \{B H\}",

year = "1993",

month = jan,

day = "30",

language = "Dutch",

volume = "137",

pages = "259--61",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Vereniging Nederlands Tijdschrift voor Geneeskunde",

number = "5",

}

TY - JOUR

T1 - Bloedingsrisico bij gebruik van fluoxetine (Prozac) of fluvoxamine (Fevarin)

AU - Ottervanger, J P

AU - van den Bemt, P M

AU - de Koning, G H

AU - Stricker, B H

PY - 1993/1/30

Y1 - 1993/1/30

N2 - Fluoxetine (Prozac) and fluvoxamine (Fevarin) are nontricyclic serotonin (5-hydroxytryptamine) reuptake inhibitors prescribed for the treatment of depression. Since these drugs block serotonin reuptake in platelets also, they might under certain conditions lead to clinically significant platelet dysfunction. Four patients are described who developed bleeding during treatment with either fluoxetine or fluvoxamine.

AB - Fluoxetine (Prozac) and fluvoxamine (Fevarin) are nontricyclic serotonin (5-hydroxytryptamine) reuptake inhibitors prescribed for the treatment of depression. Since these drugs block serotonin reuptake in platelets also, they might under certain conditions lead to clinically significant platelet dysfunction. Four patients are described who developed bleeding during treatment with either fluoxetine or fluvoxamine.

KW - Adult

KW - Female

KW - Fluoxetine/adverse effects

KW - Fluvoxamine/adverse effects

KW - Hematoma/chemically induced

KW - Hemorrhage/chemically induced

KW - Humans

M3 - Article

C2 - 8433763

SN - 0028-2162

VL - 137

SP - 259

EP - 261

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

IS - 5

ER -

Bloedingsrisico bij gebruik van fluoxetine (Prozac) of fluvoxamine (Fevarin)

Abstract

Keywords

Fingerprint

Cite this